SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes

Oral Microbiology and Immunology

Volumn 23, Issue 2, 2008, Pages 89-95

  Weistroffer, P L ^a   Joly, S ^a   Srikantha, R ^a   Tack, B F ^b   Brogden, K A ^a   Guthmiller, J M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Antimicrobial peptides; Cathelicidins; Keratinocytes; Oral bacteria; SMAP29

Indexed keywords

CATHELICIDIN; LACTATE DEHYDROGENASE; PROTEIN SMAP14A; PROTEIN SMAP18A; PROTEIN SMAP18D; PROTEIN SMAP28; PROTEIN SMAP29; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOMYCES ISRAELII; ACTINOMYCES NAESLUNDII; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DRUG CYTOTOXICITY; DRUG POTENCY; ENZYME RELEASE; FUSOBACTERIUM NUCLEATUM; KERATINOCYTE; MINIMUM INHIBITORY CONCENTRATION; MOUTH FLORA; NONHUMAN; PEPTOSTREPTOCOCCUS; PEPTOSTREPTOCOCCUS MICROS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOMYCES; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA, ANAEROBIC; BLOOD PROTEINS; CATHELICIDINS; FUSOBACTERIUM NUCLEATUM; GINGIVA; HUMANS; KERATINOCYTES; MICROBIAL SENSITIVITY TESTS; PEPTOSTREPTOCOCCUS; PORPHYROMONAS GINGIVALIS; SHEEP, DOMESTIC; STREPTOCOCCUS;

EID: 39049116537     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2007.00389.x     Document Type: Article

References (36)

1. Bartlett KH, McCray PB Jr., Thorne PS. Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin. Int J Antimicrob Agents 2004 : 23 : 606 612.
2. Benincasa M, Scocchi M, Pacor S et al. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 2006 : 58 : 950 959.
3. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003 : 254 : 197 215.
4. Brogden KA, Kalfa VC, Ackermann MR, Palmquist DE, McCray PB Jr., Tack BF. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother 2001 : 45 : 331 334.
5. Curtis MA, Kuramitsu HK, Lantz M et al. Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res 1999 : 34 : 464 472.
6. De Y, Chen Q, Schmidt AP et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000 : 192 : 1069 1074.
7. Devine DA, Marsh PD, Percival RS, Rangarajan M, Curtis MA. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology 1999 : 145 : 965 971.
8. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001 : 117 : 91 97.
9. Dowd SE, Ishizaki H. Microarray based comparison of two Escherichia coli O157:H7 lineages. BMC Microbiol 2006 : 6 : 30.
10. Ganz T. Fatal attraction evaded. How pathogenic bacteria resist cationic polypeptides. J Exp Med 2001 : 193 : F31 34.
11. Gennaro R, Zanetti M. Structural features and biologic activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 2000 : 55 : 31 49.
12. Guthmiller JM, Vargas KA, Srikantha R et al. Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother 2001 : 45 : 3216 3219.
13. Hancock RE. Peptide antibiotics. Lancet 1997 : 349 : 418 422.
14. Howell MD, Wollenberg A, Gallo RL et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006 : 117 : 836 841.
15. Johnson GK, Organ CC. Prostaglandin E2 and interleukin-1 concentrations in nicotine-exposed oral keratinocyte cultures. J Periodontal Res 1997 : 32 : 447 454.
16. Joly S, Maze C, McCray PB Jr., Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004 : 42 : 1024 1029.
17. Kalfa VC, Jia HP, Kunkle RA, McCray PB Jr., Tack BF, Brogden KA. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother 2001 : 45 : 3256 3261.
18. Khandelia H, Kaznessis YN. Molecular dynamics simulations of the helical antimicrobial peptide ovispirin-1 in a zwitterionic dodecylphosphocholine micelle: insights into host-cell toxicity. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2005 : 109 : 12990 12996.
19. Khandelia H, Langham AA, Kaznessis YN. Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions. Biochim Biophys Acta 2006 : 1758 : 1224 1234.
20. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev 2002 : 66 : 486 505.
21. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991 : 137 : 167 173.
22. Mahoney MM, Lee AY, Brezinski-Caliguri DJ, Huttner KM. Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide. FEBS Lett 1995 : 377 : 519 522.
23. Murakami M, Ohtake T, Dorschner RA, Gallo RL. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 2002 : 81 : 845 850.
24. Olczak T, Simpson W, Liu X, Genco CA. Iron and heme utilization in Porphyromonas gingivalis. FEMS Microbiol Rev 2005 : 29 : 119 144.
25. Raj PA, Antonyraj KJ, Karunakaran T. Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem J 2000 : 347 Pt 3 : 633 641.
26. Ritonja A, Kopitar M, Jerala R, Turk V. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett 1989 : 255 : 211 214.
27. Saiman L, Tabibi S, Starner TD et al. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother 2001 : 45 : 2838 2844.
28. Sawai MV, Waring AJ, Kearney WR et al. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng 2002 : 15 : 225 232.
29. Skerlavaj B, Benincasa M, Risso A, Zanetti M, Gennaro R. SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 1999 : 463 : 58 62.
30. Tack BF, Sawai MV, Kearney WR et al. SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 2002 : 269 : 1181 1189.
31. Travis SM, Anderson NN, Forsyth WR et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000 : 68 : 2748 2755.
32. Walker C. The supplemental use of antibiotics in periodontal therapy. Compend Contin Educ Dent 1999 : 20 : 4 12.
33. Yamaguchi S, Huster D, Waring A et al. Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys J 2001 : 81 : 2203 2214.
34. Yedery RD, Reddy KV. Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics - a mini review. Eur J Contracept Reprod Health Care 2005 : 10 : 32 42.
35. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995 : 374 : 1 5.
36. Zanetti M, Gennaro R, Scocchi M, Skerlavaj B. Structure and biology of cathelicidins. Adv Exp Med Biol 2000 : 479 : 203 218.